Drug intelligence / Profile preview

clonidine + fentanyl (Columbia University)

Development stage
Unknown
Lead developer
Columbia University
Modality
Small Molecules
Administration
Epidural
01

Overview

The drug name **clonidine + fentanyl-Columbia University-labor pain** refers to a clinical research comparison conducted by Columbia University (NCT01846221) evaluating two different epidural analgesic combinations for the management of breakthrough pain during advanced labor. The study specifically compared epidural clonidine (75–100 μg) combined with bupivacaine versus epidural fentanyl (75–100 μg) combined with bupivacaine. Clonidine is an alpha-2 adrenergic receptor agonist that provides non-opioid analgesia, while fentanyl is a potent mu-opioid receptor agonist. The trial aimed to determine if clonidine was superior for treating the somatic component of pain in the late first or second stages of labor. Results from the Phase 4 trial indicated that both regimens provided similar analgesic efficacy and had comparable hemodynamic side effect profiles, suggesting that clonidine is an effective alternative to fentanyl in this setting.

Other names
clonidine + fentanyl-Columbia University-labor painClonidine vs Fentanyl for Breakthrough Labor Pain
02

Targets

ADRA2B (α2B)ADRA2A (α2A)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on clonidine + fentanyl (Columbia University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clonidine + fentanyl (Columbia University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call